NexImmune, Inc. Quarterly Revenues in USD from Q2 2020 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
NexImmune, Inc. quarterly/annual Revenues history and growth rate from Q2 2020 to Q3 2022.
  • NexImmune, Inc. Revenues for the quarter ending September 30, 2022 was $0.000.
  • NexImmune, Inc. Revenues for the twelve months ending September 30, 2022 was $0.000.
  • NexImmune, Inc. annual Revenues for 2021 was $0.000.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2022-03-09
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.